$24.75
-0.34%Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. operates as a subsidiary of Select Medical Corporation.
Chief Executive Officer & Director
Compensation
$1,879,911
Executive Vice President & Chief Accounting Officer
Compensation
$1,324,933
Executive Vice President & Chief Clinical Services Officer
Compensation
$1,375,366
Executive Vice President & Chief Legal Counsel
Executive Vice President & Chief Medical Officer
Compensation
$1,431,532
Executive Vice President & Chief Operating Officer of East
Compensation
$1,361,823
Executive Vice President & Chief People Officer
Executive Vice President and Chief Information & Technology Officer
Compensation
$1,434,115
Executive Vice President and Chief Marketing & Innovation Officer
President & Chief Financial Officer
Compensation
$2,400,173
During the last 12 months, insiders have sold $6.50M worth of CON shares, with no buying activity reported.
0
0.00
260.0K
6.50M
-6.5M
-$6.50M
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
No buying activity
Ortenzio Robert A
Director
$6.50M
Strong bearish signal with $6.50M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
1 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Persistent selling pressure: Consistent insider selling with weak buy/sell ratio suggests insiders may be capitalizing on current valuation. Exercise caution and review recent earnings quality and management commentary.
CON - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 17, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 18, 2025 | May 01, 2025 | 2025 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.